or Try an Advanced Search...

    Technical Analysis for CLNN - Clene Inc.

    Grade Last Price % Change Price Change
    D 5.30 -2.03% -0.11
    CLNN closed down 2.03 percent on Tuesday, November 12, 2024, on 52 percent of normal volume. It ran into resistance at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CLNN trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    20 DMA Resistance Bearish -2.03%
    Fell Below 50 DMA Bearish -2.03%
    Bollinger Band Squeeze Range Contraction -2.03%
    Fell Below 20 DMA Bearish -6.85%
    50 DMA Support Bullish -6.85%
    Older End-of-Day Signals for CLNN ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 11 hours ago
    Fell Below Previous Day's Low about 11 hours ago
    Down 2 % about 11 hours ago
    Down 1% about 11 hours ago
    50 DMA Resistance about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CLNN Chart by TradingView
    Basic chart:

    Profile

    Clene Nanomedicine Inc., a biopharmaceutical company, develops technology solutions for drug development. The company develops Clean-Surface Nanosuspension, a technology that produces clean-surface nanocrystal medicines. Its technology also provides a platform for a pipeline of new drug candidates with application across a spectrum of diseases with unmet medical needs. The company focuses on demyelinating disorders and oncology. Clene Nanomedicine Inc. was incorporated in 2012 and is based in Salt Lake City, Utah.
    Classification
    Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Medication Technology Solutions Drug Development Nanomedicine

    Is CLNN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 11 IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements
    Oct 5 Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares
    Oct 3 IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M
    Oct 2 IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements
    Oct 1 Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
    Sep 26 IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership
    Sep 16 Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
    Sep 4 IBN Coverage: Clene (NASDAQ: CLNN) Management to Present at H.C. Wainwright Investment Conference
    Sep 3 IBN Coverage: Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases
    Sep 3 Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    See more CLNN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.0
    52 Week Low 3.8181
    Average Volume 70,942
    200-Day Moving Average 6.72
    50-Day Moving Average 5.52
    20-Day Moving Average 5.71
    10-Day Moving Average 5.82
    Average True Range 0.50
    RSI (14) 44.13
    ADX 17.15
    +DI 14.57
    -DI 17.73
    Chandelier Exit (Long, 3 ATRs) 5.00
    Chandelier Exit (Short, 3 ATRs) 6.50
    Upper Bollinger Bands 6.38
    Lower Bollinger Band 5.04
    Percent B (%b) 0.19
    BandWidth 23.47
    MACD Line 0.04
    MACD Signal Line 0.12
    MACD Histogram -0.0743
    Fundamentals Value
    Market Cap 680.6 Million
    Num Shares 128 Million
    EPS -0.41
    Price-to-Earnings (P/E) Ratio -12.93
    Price-to-Sales 73.37
    Price-to-Book 2.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.40
    Resistance 3 (R3) 6.44 6.11 6.21
    Resistance 2 (R2) 6.11 5.83 6.09 6.15
    Resistance 1 (R1) 5.71 5.66 5.55 5.67 6.09
    Pivot Point 5.38 5.38 5.30 5.36 5.38
    Support 1 (S1) 4.98 5.10 4.82 4.94 4.51
    Support 2 (S2) 4.65 4.93 4.63 4.45
    Support 3 (S3) 4.25 4.65 4.39
    Support 4 (S4) 4.21